Cumberland Pharmaceuticals Inc. CPIX
Set alert
4.22 USD -0.47 -10.02%
At close
4.18 -0.04 -0.95%
Pre-market · Nov 3, 7:02 AM ET
4.11 Day range 4.67
1.85 52-week range 9.28
- YTD
- +6.03%
- 1 year
- +41.14%
- Open
- 4.59
- Prev close
- 4.69
- Mkt cap
- 63.23M
- Vol
- 205.45K
- Avg vol
- 81.04K
- EPS
- -0.62
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.11
- High
- 4.67
- Forward P/E
- 16.07
- Beta
- 0.22
- Short ratio
- 0.92
- Inst. own
- 14.69%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.40
- 200-d avg
- 1.48
- 1y target
- 0.00
1M chart
Signals (14)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 26, 2026 | 1 week ago |
| RSI: Oversold | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 5, 2026 | 4 weeks ago |
Analyst view
Consensus: none
Price target (mean) 0.00
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.02 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.01 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | -0.01 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 3, 2019 | B. Riley Securities | Maintained | — | Buy |
| Nov 18, 2019 | B. Riley Securities | Maintained | — | Buy |
| Aug 17, 2018 | B. Riley Securities | Maintained | Buy | Buy |
| Apr 17, 2018 | B. Riley Securities | Initiated | — | Buy |
| Apr 10, 2013 | UBS | Maintained | — | Neutral |
| Nov 12, 2012 | UBS | Maintained | — | Neutral |
| Nov 9, 2012 | Wells Fargo | Downgrade | Outperform | Market Perform |